• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARTHREX, INC. SUTURE ANCH BIOCOMP SWI- VELOCK C CLD 4.75X19.1MM; FASTENER, FIXATION, BIODEGRADABLE, SOFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARTHREX, INC. SUTURE ANCH BIOCOMP SWI- VELOCK C CLD 4.75X19.1MM; FASTENER, FIXATION, BIODEGRADABLE, SOFT TISSUE Back to Search Results
Catalog Number AR-2324BCC
Device Problem Device Slipped (1584)
Patient Problems Foreign Body Reaction (1868); Rash (2033); Synovitis (2094); Osteolysis (2377)
Event Date 01/15/2014
Event Type  Injury  
Event Description
It was reported that following shoulder rotator cuff repair and biceps tenodesis with the plla suture anchors and the fiberwire, the surgeon also found osteolysis, synovitis, loose bodies, anchor pulled out of the bone and a recurrent rotator cuff tear.Three weeks post-op the patient developed a skin reaction on the surgical shoulder and arm.The dermatologist biopsied the areas with results consistent with a foreign body reaction.Patient continued to have issues with pain and the arm/shoulder rash.Follow-up investigation: patient had a (b)(6) 2013 rotator cuff repair and biceps tenodesis of the right shoulder.On (b)(6) 2014 patient had a rotator cuff repair due to worsening pain and decreasing range of motion in the right shoulder.This was performed by another surgeon at another facility.Surgeon used non-bioabsorbable suture anchors.Approximately 3 weeks after the (b)(6) 2014 surgery patient developed a raised, annular, red rash on the surgical arm and shoulder area.Patient has no known contact issues or drug allergies.The orthopedic surgeon prescribed antibiotics and topical steroid medications with no improvement.On (b)(6) 2014 patient underwent a shoulder arthroscopic exploration due to worsening pain and loss of shoulder mobility following the prior, (b)(6) 2014, rotator cuff repair.Findings during the (b)(6) 2014 surgery were consistent with: recurrent rotator cuff tear, osteolysis, chondral damage, synovitis and particulate debris.There was evidence of degradation of one of the plla arthrex anchors from the (b)(6) 2013 surgery.This anchor was removed as it was partially extruding from the bone and was producing debris in the joint.Approximately 3 weeks after the (b)(6) 2014 surgery patient developed a very similar red, raised annular rash on the surgical arm and shoulder area.The orthopedic surgeon prescribed antibiotics and topical steroid medication with no improvement.The rash worsened and spread to a larger surface area of the surgical arm and shoulder.Patient was referred to a dermatologist who biopsied the area.Findings were suggestive of a foreign body reaction.The biopsy was not consistent with a drug reaction.The rash has been relapsing and remitting, coinciding with continuing shoulder pain.
 
Manufacturer Narrative
Patient demographics (age at time of event, date of birth,weight) were requested but not provided.No further patient information was provided at the time of this report or made available in response to follow-up communication.No additional adverse consequences have been reported from this event.This device is used for treatment.The device was requested for evaluation but remains in the patient and cannot be returned therefore the complainant's event could not be verified.The cause of the event could not be determined from the information available and without device evaluation.Device history record review revealed nothing relevant to this event.Based on the information provided, the most likely cause(s) of this event is an adverse reaction of the patient to the material(s) implanted.Product directions for use warns of adverse effects like foreign body and allergic-like reactions as well as infections both deep and superficial to the implant materials.Patient sensitivity to device materials must be considered prior to implantation.This is the first complaint of this type for this part/lot combination.If additional relevant information is received, a follow-up report will be submitted.Part remained in patient.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUTURE ANCH BIOCOMP SWI- VELOCK C CLD 4.75X19.1MM
Type of Device
FASTENER, FIXATION, BIODEGRADABLE, SOFT TISSUE
Manufacturer (Section D)
ARTHREX, INC.
1370 creekside boulevard
naples FL 34108 194
Manufacturer (Section G)
ARTHREX, INC.
1370 creekside boulevard
naples FL 34108 194
Manufacturer Contact
vik bajnath, sr. mdr analyst.
1370 creekside boulevard
naples, FL 34108-1945
8009337001
MDR Report Key4869029
MDR Text Key21081290
Report Number1220246-2015-00168
Device Sequence Number1
Product Code MAI
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K101823
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Patient
Type of Report Initial
Report Date 06/05/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/01/2014
Device Catalogue NumberAR-2324BCC
Device Lot Number569224
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Initial Date Manufacturer Received 06/05/2015
Initial Date FDA Received06/25/2015
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/01/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AR-1670BC, TENODESIS SCREW, LOT 534635.
Patient Outcome(s) Other;
-
-